CLICK HERE FOR ORIGINAL POST was originally published on this website

Condition:   Irritable Bowel Syndrome
Interventions:   Drug: Rifaximin 550 MG;   Other: Low FODMAP Diet
Sponsors:   University of Michigan;   Michigan Institute for Clinical and Health Research (MICHR)
Not yet recruiting – verified July 2017